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Abstract 
While studies of ATG genes in knockout models led to an explosion of knowledge about the 
functions of autophagy components, the exact roles of LC3 and GABARAP proteins are still 
poorly understood. A major drawback for their understanding is that the available interactome 
data was largely acquired using overexpression systems. To overcome these limitations, we 
employed CRISPR/Cas9-based genome-editing to generate a panel of cells in which human 
ATG8 genes were tagged at their natural chromosomal locations with an N-terminal affinity 
epitope. This cellular resource was exemplarily employed to map endogenous GABARAPL2 
protein complexes using interaction proteomics. This approach identified the ER-associated 
protein and lipid droplet (LD) biogenesis factor ACSL3 as a stabilizing GABARAPL2-binding 
partner. GABARAPL2 bound ACSL3 in a manner dependent on its LC3-interacting regions 
whose binding site in GABARAPL2 was required to recruit the latter to the ER. Through this 
interaction, the UFM1-activating enzyme UBA5 became anchored at the ER. Further, ACSL3 
depletion and LD induction affected the abundance of several ufmylation components and ER-




























From yeast to humans ATG8s are highly conserved proteins. While there is only a single Atg8 
in yeast, the human ATG8 (hATG8) family is subdivided into the orthologs microtuble-
associated protein 1A/1B light chain 3 (MAP1LC3) including LC3A, LC3B, and LC3C as well 
as -aminobutyric acid receptor-associated protein (GABARAP) including GABARAP, 
GABARAPL1 and GABARAPL2 (Slobodkin and Elazar, 2013). All six hATG8 proteins share 
the same, ubiquitin-like fold although they do not exhibit any sequence homologies with 
ubiquitin. However, within and between the ATG8 subfamilies, the amino acid sequences 
show high similarities (Shpilka et al., 2011). A major feature of LC3 and GABARAP proteins 
is their covalent conjugation to the phospholipid phosphatidylethanolamine (PE). This process 
is initiated by the cysteine proteases ATG4A-D that cleave all hATG8 family members to 
expose a C-terminal glycine residue and is followed by the activation of LC3s and GABARAPs 
through the E1-like activating enzyme ATG7. PE-conjugation of hATG8 proteins is 
subsequently accomplished in a concerted action of the E2-like conjugating enzyme ATG3 
and the E3-like ligase scaffold complex ATG12-ATG5-ATG16L1. PE-hATG8 conjugates are 
reversible through cleavage by ATG4A-D (Mizushima et al., 2011). 
The best understood function of hATG8s is in macroautophagy (hereafter referred to as 
autophagy) which is a highly conserved degradation pathway that eliminates defective und 
unneeded cytosolic material and is rapidly upregulated by environmental stresses such as 
nutrient deprivation. In the past years, it was shown that autophagy is capable of selectively 
recognizing and engulfing divers cargo such as aggregated proteins (aggrephagy), pathogens 
(xenophagy) or mitochondria (mitophagy) with the help of specific receptor proteins (Kirkin 
and Rogov, 2019). Initiation of autophagy leads to the formation of phagophores (also called 
isolation membranes) from preexisting membrane compartments, such as the ER. Elongation 
and closure of isolation membranes leads to engulfment of cargo inside double membrane 
vesicles termed autophagosomes. Fusion of autophagosomes with lysosomes forms 
autolysosomes in which captured cargo is degraded in bulk by lysosomal hydrolases (Dikic 
and Elazar, 2018). During this process, GABARAPs and LC3s are associated with the outer 
and inner membrane of phagophores and regulate membrane expansion (Xie et al., 2008), 
cargo receptor recruitment (Stolz et al., 2014), closure of phagophores (Weidberg et al., 2011) 
and the fusion of autophagosomes with lysosomes (Nguyen et al., 2016). 
Besides autophagy, GABARAPs and LC3s are implicated in a number of other cellular 
pathways. For example, GABARAP was found as interactor of the GABA receptor and 























1999), while GABARAPL2 was identified as modulator of Golgi reassembly and intra-Golgi 
trafficking (Legesse-Miller et al., 1998, Muller et al., 2002). GABARAPs were also found as 
essential scaffolds for the ubiquitin ligase CUL3KBTBD6/KBTBD7 (Genau et al., 2015). Among 
others, LC3s have regulatory functions in RhoA dependent actin cytoskeleton reorganization 
(Baisamy et al., 2009) as well as in the regulation of ER exit sites (ERES) and COPII-
dependent ER-to-Golgi transport (Stadel et al., 2015). This high functional diversity of 
GABARAPs and LC3s implies that these proteins are more than autophagy pathway 
components and that there are possible other unique functions of individual hATG8 proteins 
to be unraveled.  
So far, interactome and functional analyses of LC3s and GABARAPs were mostly done in 
cells overexpressing one of the six hATG8 family members (Behrends et al., 2010, Popovic et 
al., 2012). This raises the concern that an overexpressed hATG8 protein might take over 
functions or interactions of one of the other family members due to their high sequential and 
structural similarity. A lack of isoform specific antibodies further complicates the analysis of 
distinct functions of hATG8s. To facilitate the study of endogenous GABARAPs and LC3s, it 
is important to generate alternative resources and tools such as the multiple hATG8 knockout 
cell lines (Nguyen et al., 2016) or the hATG8 family member-specific peptide sensors (Stolz 
et al., 2017). To circumvent the hATG8 antibody problem, we used CRISPR/Cas9 technology 
to seamlessly tag hATG8 genes at their natural chromosomal locations. The generated cell 
lines (hATG8endoHA) express N-terminally hemagglutinin (HA)-tagged hATG8 family members 
at endogenous levels and are a powerful tool to study the functions of individual GABARAPs 
and LC3s. All created cell lines were tested for their correct sequence and functionality. As a 
proof of concept, we performed interaction proteomics with the GABARAPL2endoHA cell line and 
characterized the interaction with the novel binding partner ACSL3. 
 
Results 
Establishment of cells carrying endogenously HA tagged LC3s and GABARAPs 
Complementary to our previously reported LC3CendoHA HeLa cell line (Le Guerroue et al., 2017) 
we sought to employ CRISPR-mediated gene-editing to generate a panel of cells in which the 
remaining five hATG8 family members are seamlessly epitope tagged at their natural 
chromosomal locations. To this end, we directed Cas9 to cleave DNA at the vicinity of the start 
codon of LC3 and GABARAP genes in order to stimulate microhomology-mediated integration 
of a sequence encoding for a single HA-tag using a double-stranded DNA donor molecule 























homology templates in which the blasticidine resistant gene, a P2A sequence and the open 
reading frame of the HA-tag were flanked by homology arms to the 5’UTRs and first exons of 
the LC3/GABARAP genes (Fig. S1A). In parallel, we designed single guide RNAs (sgRNAs) 
for all hATG8 genes except LC3C and cloned them into pX330, a SpCas9 expressing vector 
(Fig. S1A). We then transfected HeLa cells with corresponding pairs of homology template 
and sgRNA for each LC3/GABARAP gene. After selection with blasticidine, single cell clones 
were SANGER sequenced to confirm seamless and locus-specific genomic insertion of the 
HA-tag. While we obtained correct clones for GABARAP, GABARAPL1, GABARAPL2 and 
LC3B (Fig. S1B), cells that received the homology template and sgRNA for LC3A did not 
survive the antibiotic selection. We assume that this is due to the lack of LC3A in HeLa cells 
as it is reported that LC3A expression is suppressed in many tumor cell lines (Bai et al., 2012). 
Immunoblot analysis of the sequence-validated clones and the parental cells revealed the 
presence of the HA-tag in the engineered cell lines that corresponded to the size of the tagged 
LC3/GABARAP protein (Fig. 1A, Fig. S2A-C). Gene specific CRISPR/Cas9-editing was further 
confirmed by RNAi-mediated depletion of endogenous LC3 or GABARAP proteins in the 
corresponding HA-tagged hATG8 cell lines (Fig. 1B, Fig. S2D-F). Consistently, confocal 
microscopy of GABARAPL2endoHA cells showed a substantially decreased HA immunolabeling 
upon knockdown of GABARAPL2 (Fig. 1C). Next, we examined the integrity of the tagged 
LC3/GABARAP proteins by monitoring their conjugation to PE in response to treatment with 
small molecule inhibitors which either increase lipidation (Torin1), block autophagosomal 
degradation (Bafilomycin A1 (BafA1)) or prevent ATG8-PE conjugate formation (ATG7 
inhibitor). As expected, GABARAPL2endoHA, GABARAPendoHA and LC3BendoHA cell lines showed 
treatment-specific lipidation levels of the respective tagged hATG8 protein (Fig. 1D; Fig. 
S2G,I). We also detected lipidated GABARAPL1, though in a manner that was independent 
from induction or blockage of autophagy (Fig. 3E). However, as expected autophagy induction 
robustly decreased HA-GABARAPL1 protein levels in GABARAPL1endoHA cells while blockage 
of autophagosomal degradation led to the opposite phenotype (Fig. S2H). Next, we analyzed 
the subcellular distribution of one of the HA-tagged hATG8 proteins (i.e. GABARAPL2) in 
basal and autophagy-modulating conditions using confocal microscopy. In GABARAPL2endoHA 
cells, HA-GABARAPL2 was indeed found to colocalize with the autophagosomal and -
lysosomal markers p62, LC3B and LAMP1 and this colocalization increased upon combination 
treatment with Torin1 and BafA1 (Fig. 1E-G). Together, we successfully engineered cell lines 

























Mapping the endogenous GABARAPL2 interactome 
Next, we selected GABARAPL2endoHA cells for a proof-of-principle immunoprecipitation (IP) 
followed by mass spectrometric (MS) analysis to identify new candidate binding partners of a 
hATG8 family member at endogenous levels. To distinguish between candidates that bind 
preferentially to PE-conjugated versus unconjugated GABARAPL2 we treated stable isotope 
labeling with amino acids in cell culture (SILAC)-labeled GABARAPL2endoHA cells with Torin1 
and BafA1 (light) or ATG7 inhibitor (heavy). Equal amounts of heavy and light SILAC cells 
were mixed, lysed and subjected to an HA-IP. Immune complexes were eluted and size 
separated by gel electrophoresis followed by in-gel tryptic digest, peptide extraction and 
desalting prior to analysis by liquid chromatography tandem MS. SILAC labeled parental HeLa 
cells differentially treated with Torin1/BafA1 or ATG7 inhibitor served as a negative control. In 
duplicate experiments, we identified a total of 168 proteins whose abundances in 
GABARAPL2 immunoprecipitates were altered by at least 2.8-fold (log2 SILAC ratio ≥1.5 or ≤-
1.5) in response to modulation of the GABARAPL2 conjugation status (Fig. 2A). Among these 
regulated proteins were well-characterized hATG8 binding proteins such as ATG7, CCPG1 
and SQSTM1 (also known as p62) as well as several candidate interactors of LC3 and 
GABARAP proteins previously found in large-scale screening efforts such as the mitochondrial 
outer membrane protein VDAC1, the nucleoprotein AHNAK2, the translation initiation factor 
EIF4G1 and the small GTPase IRGQ (Ewing et al., 2007, Rolland et al., 2014) (Fig. 2A). In 
addition, a number of known hATG8 binding proteins including UBA5, HADHA, HADHB, 
RB1CC1, TRIM21 and IPO5 was found to bind GABARAPL2 independent of its lipidation 
status since these proteins did not display substantial changes in their SILAC ratios.  
 
ACSL3 is a novel binding partner of GABARAPL2 
Since functional annotation analysis using DAVID revealed ‘fatty acid metabolism’ as a term 
previously not associated with LC3/GABARAP-interacting proteins (Fig. S2J), we focused on 
the proteins found in this category. In particular, the long-chain-fatty-acid-CoA ligase 3 
(ACLS3) attracted our attention as it was the only ER-localized protein among these 
candidates. To validate ACSL3 as novel GABARAPL2 interacting protein, we performed HA-
IPs on lysates derived from parental and GABARAPL2endoHA cells which were either transiently 
transfected with ACSL3-myc, myc-p62 or -ATG7 or left untreated. Notably, p62 and ATG7 
served as positive controls. Immunoblotting with epitope tag- and gene-specific antibodies 























with endogenous GABARAPL2 (Fig. 2B,C). Thus, these results indicate that our hATG8endoHA 
cells are indeed valuable tools to examine the LC3 and GABARAP interactome at endogenous 
levels and to identify novel binding partners such as ACSL3. 
 
GABARAPL2 is stabilized by ACSL3 
Since GABARAPL2 is involved in autophagic cargo engulfment (Schaaf et al., 2016), we 
tested whether ACSL3 is an autophagy substrate or serves as selective autophagy receptor. 
However, stimulation of GABARAPL2endoHA cells with Torin1, BafA1, a combination of both or 
with ATG7 inhibitor showed that ACSL3 protein levels did not change upon autophagy 
induction or blockage (Fig. 3A). Likewise, depletion of GABARAPL2 had no effects on ACSL3 
abundance (Fig. 3B). Thus, these results indicate that ACSL3 is neither a substrate nor a 
receptor of autophagy under these conditions. Next, we examined the effects of ACSL3 
knockdown on GABARAPL2. Treatment of GABARAPL2endoHA cells with two different ACSL3 
siRNAs showed a significant decrease of GABARAPL2 protein levels (Fig. 3C). To rule out 
that this phenotype is due to a global perturbation of the ER, we probed for the integrity of this 
organelle in cells depleted of ACSL3 using immunolabeling with Calnexin and the ER exit site 
marker SEC13. However, neither the meshwork appearance nor the exist sites of the ER 
showed any overt alterations (Fig. S3A,B). Given the high structural and functional similarity 
between LC3 and GABARAP family members we addressed whether ACSL3 depletion 
likewise impacts on the protein abundance of the other hATG8 family members. Unexpectedly, 
ACSL3 knockdown experiments in GABARAPendoHA, GABARAPL1endoHA and LC3BendoHA cells 
did not show any significant reduction in the respective HA-tagged hATG8 proteins (Fig. 3D-
F). In contrast, we found that LC3B protein levels significantly increased upon ACSL3 
depletion (Fig. 3F), suggesting that reduced GABARAPL2 levels might be compensated by 
increased expression of LC3B. Intriguingly, we observed that GABARAPL2 protein levels are 
restored in RNAi-treated GABARAPL2endoHA cells treated with BafA1 to block autophagosomal 
degradation but not with the proteasome inhibitor Bortezomib (Btz) (Fig. 3G). Together, these 
results indicate that ACSL3 is not degraded by autophagy but rather serves as a specific 
stabilizing factor of GABARAPL2 at the ER. 
 
GABARAPL2 localizes with ACSL3 at the ER  
ACSL3 is one of five acyl-CoA synthetases and catalysis the conjugation of CoA to long chain 
fatty acids to form acyl-CoA (Soupene and Kuypers, 2008). Besides ACSL3 was found to 























Kassan et al., 2013). Consistent with its cellular role, ACSL3 is inserted with its N-terminal 
helix region midway into the lipid bilayer of the ER membrane or integrated into the monolayer 
of lipid droplets (LD) while its C-terminal part encompassing the AMP-binding domain is facing 
to the cytoplasm (Brasaemle et al., 2004, Ingelmo-Torres et al., 2009, Poppelreuther et al., 
2012). To further validate the GABARAPL2-ACSL3 interaction, we sought to examine the 
subcellular localization of both proteins by confocal microscopy. However, as there were no 
suitable antibodies for immunofluorescence staining of endogenous ACSL3, we gene-edited 
GABARAPL2endoHA cells to express ACSL3 tagged at its C-terminus with NeonGreen (Fig. 
S1A,C). Immunoblot analysis of these newly established 
GABARAPL2endoHA/ACSL3endoNeonGreen cells in comparison with GABARAPL2endoHA and 
parental Hela cells transfected with TOMM20-NeonGreen confirmed the correct size of the 
ACSL3-NeonGreen fusion (approximately 106 kDa; ACSL3 80 kDa + NeonGreen 26 kDa) 
(Fig. 4A). Colocalization of ACSL3-NeonGreen with the ER-membrane localized chaperone 
Calnexin demonstrated that the NeonGreen tag did not interfere with the ER localization of 
ACSL3 (Fig. 4B). As ACSL3 is essential for LD formation, we tested whether the ACSL3-
NeonGreen chimera is fully functional. Thereto, GABARAPL2endoHA/ ACSL3endoNeonGreen cells 
were treated with oleic acid to induce LD formation or EtOH as control prior to fixation and 
labeling of phospholipids and neutral lipids. Confocal microscopy showed a clear 
colocalization of ACSL3 with phospholipids and neutral lipids in control cells while ACSL3 
redistributed in the phospholipid monolayer of LDs when cells were treated with oleic acid for 
24 hrs (Fig. 4C). Next, we analyzed fixed and HA-immunolabeled 
GABARAPL2endoHA/ACSL3endoNeonGreen cells by confocal microscopy and super-resolution radial 
fluctuations (SRRF) imaging. Consistent with our biochemical experiment, we observed partial 
colocalization of endogenous GABARAPL2 and ACSL3 (Fig. 4D). Together, these results 
show that NeonGreen tagged ACSL3 is correctly localized at the ER membrane, integrates 
into the monolayer of LDs upon free fatty acid treatment and associates with GABARAPL2 at 
the ER. 
 
ACSL3 binds GABARAPL2 in a LIR-dependent manner  
Interaction between hATG8 proteins and their binding partners involves an ATG8 family-
interacting motif (AIM; also known as LC3-interacting region (LIR)) in the hATG8 interactors 
and the LIR-docking site (LDS) in LC3 and GABARAP proteins (Noda et al., 2008, Pankiv et 
al., 2007, Rogov et al., 2014). Amino acid sequence analysis of ACSL3 with iLIR (Kalvari et 
al., 2014) and manual inspection revealed four potential LIRs (LIR-1: 65-71, LIR-2: 135-140, 























of these sites to bind GABARAPL2 we performed binding experiments with purified GST-
tagged wild-type and a LIR-binding deficient GABARAPL2 mutant in which the relevant amino 
acids of the LDS were replaced with alanine (i.e. Y49A/L50A). These two GABARAPL2 
variants were incubated with lysates derived from HeLa cells stably expressing full-length 
ACSL3 or two fragments thereof. While the first fragment spanned residues 1-85 and included 
the ER membrane-binding domain and LIR-1, the second fragment ranged from residues 86-
718 and contained the AMP binding site, LIR-2-4 (Fig. 5A). Immunoblot analysis of the 
pulldown assay showed binding of wild-type GABARAPL2 to full-length ACSL3 and both of its 
fragments (Fig. 5B), indicating that ACSL3 contains at least two distinct binding sites for 
GABARAPL2. Intriguingly, GABARAPL2 lacking a functional LDS did not interact with ACSL3 
86-718 while it retained binding to the wild-type ACSL3 and fragment 1-85 (Fig 5B). This 
suggests that GABARAPL2 employs its LDS to bind to a LIR within residues 86-718 of ACSL3 
while GABARAPL2 seem to employ a different binding site to interact with a motif in the 
preceding ACSL3 sequence. To start dissecting the relevance of our binding model for the 
recruitment of GABARAPL2 to ACSL3 at the ER, we subjected HeLa cells stably expressing 
wild-type or LIR-binding deficient GABARAPL2 to subcellular fractionation using differential 
centrifugation. Consistent with our finding that ACSL3 binds GABARAPL2 in a LIR-dependent 
manner, immunoblot analysis revealed that wild-type GABARAPL2 is found in the ER fraction 
but GABARAPL2 ΔLDS fail to cofractionate with the ER (Fig. 5C, Fig. S4B). Taken together 
these results indicate that the ACSL3-GABARAPL2 interaction involves more than one binding 
motif and binding site in GABARAPL2 and ACSL3 and that LIR-dependent ACSL3 binding is 
required for the ER recruitment of GABARAPL2. 
 
ACSL3 anchors UBA5 to the ER membrane  
To better understand the biological significance of the GABARAPL2-ACSL3 interaction, we 
turned our attention to known GABARAPL2 binding proteins and in particular to the ubiquitin-
like modifier activating enzyme 5 (UBA5) (Komatsu et al., 2004), which was recently shown to 
be recruited to the ER membrane in a GABARAPL2-dependent manner (Huber et al., 2019). 
By subjecting lysates derived from parental and GABARAPL2endoHA cells that were transiently 
transfected with myc-UBA5 or left untreated to HA-IPs, we confirmed the GABARAPL2-UBA5 
interaction (Fig. 6A) and demonstrated that it occurs at endogenous levels (Fig. 6B). Since 
ACSL3 binds GABARAPL2 at the ER membrane, we investigated whether ACSL3 also 
colocalizes with UBA5. Indeed, immunolabeling of fixed GABARAPL2endoHA/ACSL3endoNeonGreen 
cells with an anti-UBA5 antibody followed by SRRF imaging showed partially colocalization of 























cells with anti-UBA5 and anti-HA antibodies we also observed triple localization of ACSL3, 
GABARAPL2 and UBA5 (Fig. 6D). Next, we examined the effect of GABARAPL2 depletion on 
the ACSL3-UBA5 interaction. Thereto, we transfected HeLa cells stably overexpressing 
ACSL3-HA with myc-UBA5 and a siRNA against GABARAPL2 or a non-targeting control 
followed by HA-IP. Consistent with the notion that GABARAPL2 recruits UBA5 to ACSL3, we 
observed a clear reduction of UBA5 levels in ACLS3 immunoprecipitates upon GABARAPL2 
knockdown (Fig. 6E). Lastly, we asked whether the ACSL3-UBA5 interaction is modulated by 
lipid stress. To address this question, we performed myc-IPs on lysates derived from myc-
UBA5-transfected mock or ACSL3-HA expressing HeLa cells that were grown in the absence 
and presence of oleic acid. Remarkably, we found that UBA5 associates with ACSL3 
independent of its activity during LD formation (Fig. 6F). Overall, these results suggest that 
ACSL3, GABARAPL2 and UBA5 form a complex at the ER membrane in dependency of 
GABARAPL2. 
 
ACSL3 regulates ufmylation pathway components 
Since we found that ACSL3 stabilizes GABARAPL2, we investigated whether ACSL3 
depletion has similar effects on UBA5 protein abundance. For this purpose, GABARAPL2endoHA 
cells were transfected with siRNA against ACSL3 or a non-targeting control and grown in the 
absence or presence of BafA1 or Btz. Indeed, we observed that protein levels of UBA5 
decreased upon ACSL3 depletion but they were not restored by blockage of autophagosomal 
or proteasomal degradation (Fig. 7A,B). While depletion of GABARAPL2 had no effects on 
UBA5 protein levels (Fig. 3B). This supports the notion that UBA5 and GABARAPL2 form a 
functional unit which is regulated by ACSL3. UBA5 is part of the conjugation system, termed 
ufmylation, that covalently attaches the ubiquitin-like protein ubiquitin fold modifier 1 (UFM1) 
to target proteins through an E1-E2-E3 multienzyme cascade. The E1-like enzyme UBA5 
activates UFM1 by forming a thioester bond between its active site and the exposed C-terminal 
glycine of UFM1 (Komatsu et al., 2004). The UFM1-conjugating enzyme 1 (UFC1) then 
transfers UFM1 from UBA5 to the UFM1-protein ligase 1 (UFL1) which mediates the 
attachment to target proteins (Komatsu et al., 2004, Tatsumi et al., 2010). While UFC1 is 
cytosolic, the ER-membrane bound protein DDRGK1 anchors UFL1 to the ER membrane (Wu 
et al., 2010) and is reported to be one of the few known ufmylation targets besides RPL26 
(Walczak et al., 2019), RPN1 (Liang et al., 2019) and ASC1 (Yoo et al., 2014) (Tatsumi et al., 
2010). While the consequences of ufmylation remains poorly understood at the mechanistic 
level, the UFM1 conjugation pathway has been linked to the ER stress response (Lemaire et 























cellular homeostasis (Zhang et al., 2015) and breast cancer progression (Yoo et al., 2014). 
Since the stability of UBA5 and its ER-recruiting factor GABARAPL2 was controlled by ACSL3, 
we probed whether it also regulates the abundance of the other proteins in the ufmylation 
cascade. Knockdown experiments revealed that the protein levels of UFL1 and DDRGK1 were 
significantly decreased upon ACSL3 depletion while the abundance of UFC1 was significantly 
increased. Conjugated UFM1 was largely unchanged (Fig. 7A,B, Fig. S4C). The observation 
that the protein levels of UBA5, UFL1 and DDRGK1 were not restored by blockage of 
autophagy or the proteasome (Fig. 7A,B) indicates that these ufmylation factors are most likely 
regulated at the transcriptional level. Together, this suggest that ACSL3 not only anchors 
UBA5 but might act as novel regulator of the ufmylation cascade.  
 
 LDs regulate UFM1 conjugation and ER-phagy 
The finding that the LD biogenesis factor ACSL3 stabilizes several components of the UFM1 
conjugation pathway raises the question whether LD biogenesis and ufmylation are 
functionally coupled. To test this hypothesis, we monitored the ufmylation pathway in response 
to induction of LD formation in GABARAPL2endoHA cells grown in the absence and presence of 
oleic acid for 0.5, 4 and 8 hrs, respectively. While UBA5 levels significantly decreased in the 
course of 8 hrs oleic acid treatment, there was no effect on UFC1 (Fig. 7C,D). In contrast, the 
protein levels of DDRGK1 and UFL1 both decreased in the first 4 hrs of incubation with oleic 
acid but after 8 hrs at least DDRGK1 levels were almost restored (Fig. 7C,D). Interestingly, 
we detected significantly more conjugated UFM1 (~35 kDa) after 4 hrs of oleic acid incubation 
(Fig. S4D) which might be due to altered ufmylation and de-ufmyltion dynamics. Given that 
LD formation induced a substantial suppression of several ufmylation components and that 
these components was recently shown to be required for starvation-induced, ER sheet-
targeting selective autophagy (Liang et al., 2019), we examined whether induction of LD 
blocks this ER-phagy pathway. Thereto, we employed the recent developed ER-autophagy 
tandem reporter system which allows the quantification of reticulolysosomes (Liang et al., 
2018). Briefly, HeLa cells were transfected with mCherry-eGFP-RAMP4 and starved with 
EBSS for 8 hrs in combination with either EtOH or oleic acid. As expected, we observed a 
robust decrease in the numbers of red-only puncta which indicates reduced reticulolysosomes 
and hence an inhibition of ER-phagy (Fig. 8A,B). Together, these results indicate that the 
ufmylation cascade is differentially regulated during induction of LD and that the ACSL3-

























In this study, we identified the ER-associated protein ACSL3 as novel binding partner of 
GABARAPL2 and UBA5 using a CRISPR/Cas9 generated GABARAPL2endoHA cell line. 
Furthermore, we provide evidences for the regulation of ufmylation through ACSL3 and LD 
biogenesis.  
In our interactome screen with endogenously tagged GABARAPL2 we found ACSL3, which 
we confirmed as GABARAPL2 interactor by immunoprecipitations, GST pulldowns and SRRF 
imaging. Moreover, our data suggest, that this interaction is mediated by a LIR and one 
additional binding motif in ACSL3. By using GABARAPL2 LIR-binding deficient mutants as 
well as N- and C-terminal ACSL3 fragments we narrowed down the LIR in ACSL3 within the 
amino acids 86-718, thereby excluding candidate LIR-1. Given that candidate LIR-2 is 
localized within the AMP-binding domain of ACSL3 and therefore unlikely accessible, 
candidate LIR-3 or -4 might mediate the binding to the LDS of GABARAPL2 (Fig. S4A). In 
addition, our binding studies indicate a GABARAPL2 LDS-independent binding motif within 
residues 1-85 of ACSL3. In addition to the LIR/LDS pairing, Marshall and colleagues recently 
reported an alternative hATG8 interaction modus in which binding partners employ a ubiquitin-
interacting motif (UIM) to bind to an UIM-docking site (UDS) in LC3 and GABARAP proteins 
(Marshall et al., 2015). According to the UIM consensus sequence (Marshall and Vierstra, 
2019) we indeed found a potential UIM (amino acids 73-81) in ACSL3 by manual sequence 
inspection (Fig. S4A). However, this candidate UIM is reversed in its sequence similar to 
inverted SUMO interaction motifs (Matic et al., 2010). Whether and how this UIM bind to 
GABARAPL2’s UDS remains to be structurally determined. Importantly, our subcellular 
fractionation assay revealed that GABARAPL2 recruitment to the ER membrane is dependent 
on the LIR of ACSL3 as the LDS GABARAPL2 mutant was dramatically reduced in the ER 
membrane fractions compared to wild-type GABARAPL2.  
GABARAP proteins were shown to mediate ER recruitment of UBA5 to bring it in close 
proximity to the membrane bound UFM1 E3 enzyme complex composed of UFL1, DDRGK1 
and CDK5R3, thereby facilitating ufmylation (Huber et al., 2019). However, since GABARAPs 
are not known to be conjugated to PE at the ER, the molecular basis of this recruitment 
process was not clear. Here, we provided evidence that ACSL3 function to anchor UBA5 at 
the ER membrane. Given that UBA5 employs an atypical LIR to bind both GABARAPL2 and 
UFM1 and that the latter is able to outcompete GABARAPL2 binding of UBA5 in vitro (Habisov 
et al., 2016), it is tempting to speculate that GABARAPL2 interacts with UBA5 until UFM1 























over to ACSL3 (Fig. 8C). However, the binding mode of ACSL3 and UBA5 remains to be 
explored. 
While targets of ufmylation are still largely unknown, three of the known UFM1-modified 
proteins are linked to the ER. Firstly, UFM1 conjugation of DDRGK1 is essential for the 
stabilization of the serine/threonine-protein kinase/endoribonuclease IRE1 (inositol-requiring 
enzyme 1) (Liu et al., 2017, Yoo et al., 2014). Secondly, it was shown that the 60S ribosomal 
protein L26 (RPL26) is exclusively ufmylated and de-ufmylated at the ER membrane (Walczak 
et al., 2019). Thirdly, Ribophorin1 (RPN1), an ER transmembrane protein and part of the 
oligosaccharyltransferase complex, is ufmylated in a DDRGK1-dependent manner (Liang et 
al., 2019, Kelleher et al., 1992). Overall, emerging evidence points to a role of the UFM1 
conjugation system as regulator of ER homeostasis, ER stress response and ER remodeling. 
Disruption of protein folding and accumulation of unfolded proteins in the ER are hallmarks of 
ER stress which leads to the induction of the unfolded protein response (UPR) via one of these 
three key factors: IRE1, PKR-like ER protein kinase (PERK) or activating transcription factor 
6 (ATF6). Protein degradation, reduction of protein synthesis and enlargement of the ER 
capacity are part of the UPR (Karagoz et al., 2019). In different cell lines and animal models, 
it was reported that ufmylation is upregulated via IRE1 or PERK upon ER stress, while 
depletion of ufmylation components induce the UPR (Gerakis et al., 2019, Lemaire et al., 2011, 
Zhang et al., 2015, Zhang et al., 2012, Zhu et al., 2019). Upon re-established ER homeostasis, 
ufmylation coordinates the elimination of extended ER membranes through ER-phagy (Liang 
et al., 2019, DeJesus et al., 2016).  
In our present study, we identified LD formation stimulated by oleic acid treatment as novel 
regulator of ufmylation. LD biogenesis starts with lens formation, an accumulation of neutral 
lipids between the ER membrane leaflets until LDs eventually bud from the ER. The 
hydrophobic neutral lipid core of a LD is surrounded by a phospholipid monolayer with the 
origin of the outer ER membrane leaflet (Henne et al., 2018). ACSL3 was identified as LD 
associated protein and essential for LD biogenesis, expansion and maturation (Fujimoto et al., 
2004, Kassan et al., 2013). During initiation of LD biogenesis ACSL3 is translocated and 
concentrated to pre-LDs to drive LD expansion by mediating acyl-CoA synthesis. However, 
cells with enzymatically inactive ACSL3 are still able to form LDs, suggesting additional 
functions of ACSL3 in LD biogenesis (Kassan et al., 2013, Kimura et al., 2018). Induction of 
LD formation induced by oleic acid which requires ACSL3 resulted in a reduction of UBA5, 
UFL1 and DDRGK1 protein levels and thus potentially shut down of UFM1 conjugation (Fig. 
7C,D, Fig. 8C). Interestingly, depletion of ACSL3 led to a similar phenotype with regard to 
these three ufmylation components. Together, these results suggest that ACSL3 regulates 























that inhibition of proteasomal or lysosomal degradation did not rescue this phenotype suggests 
that these components of the ufmylation machinery are probably downregulated at the 
transcriptional level. To what extend this involves one of the three UPR factors IRE1, PERK 
or ATF6 remains to be examined. Consisting with the recent finding that ER-phagy is blocked 
by inhibition of the interaction between DDRGK1 and UFL1 (Liang et al., 2019), we observed 
that LD biogenesis inhibits the remodeling of ER membranes by ER-phagy. While DDRGK1 
protein levels are restored 8 hrs after induction of LD formation it needs to be further 
investigated when UFL1 protein levels are reestablished and therefore ER-phagy is restored. 
Collectively, these findings underline the potential of our CRISPR/Cas9 gene-edited cell lines 
to uncover novel cellular pathways involving hATG8 family members without the need of 
overexpression systems, thereby complementing the recently generated LC3 and GABARAP 
knockout cell lines (Nguyen et al., 2016). Together with the LC3CendoHA cell line that we 
previously reported (Le Guerroue et al., 2017), this cellular resource circumvents the drawback 
of unspecific LC3 and GABARAP antibodies and hence will greatly facilitate the functional 
dissection of individual hATG8 proteins.  
 
Material and Methods 
Cell culture and treatments 
HeLa cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) + GlutaMAX-I 
(Gibco) supplemented with 10 % fetal bovine serum (FBS) and 1mM sodium pyruvate (Gibco) 
and grown at 37° C and 5 % CO2. For SILAC mass spectrometry, cells were grown in lysine- 
and arginine-free DMEM (Gibco) supplemented with 10 % dialyzed FBS, 2 mM glutamine 
(Gibco), 1 mM sodium pyruvate (Gibco) and 146 mg/ml light (K0, Sigma) or heavy L-lysine 
(K8, Cambridge Isotope Laboratories) and 84 mg/ml light (R0, Sigma) or heavy L-arginine 
(R10, Cambridge Isotope Laboratories). SILAC labeled cells were counted after harvesting, 
mixed 1:1 and stored at -80° C. For selection Puromycin (2 µg/ml) or Blasticidine (4 µg/ml) 
was added to the growth medium. The following reagents were used for treatments: oleic acid 
(EMD Millipore, 4954, 600 µm in EtOH, 0.5, 4, 8 or 24 hrs), Bafilomycin A1 (Biomol, Cay11038-
1, 200 nM in DMSO, 2 hrs), Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC 
Labs B-1408, 1 µM in PBS, 8 hrs), ATG7 inhibitor (Takeda ML00792183, 1 µM in DMSO, 24 

























Plasmids and stable cell lines 
attB flanked ORFs, generated by PCR were cloned into the Gateway entry vector pDONR233. 
ORFs from pDONR233 constructs were introduced into one of the following destination 
vectors using recombination cloning: pHAGE-N-Flag-HA, pHAGE-C-FLAG-HA, pET-60-
DEST, pEZYmyc-HIS (Addgene, #18701) or pDEST-myc. Stable HA-GABARAPL2 and 
ACSL3-HA expressing cells were generate by lentiviral transduction followed selection with 2 
µg/ml Puromycin. pEZY and pDEST constructs were used for transient expression in cells 
(see transfection). 
 
Site directed mutagenesis 
For site directed mutagenesis, primers were designed with Quick Change Primer Design 
software (Agilent Technologies). First, forward and reverse primers were used in individual 
PCR reactions using KOD Hot Start polymerase (Merck Millipore), according to the instruction 
of the manufacturer, with the appropriate pDONOR-ORF plasmid as template. In a second 
step, PCR reactions were combined and plasmids with the mutated ORF was generated 
through a second round of PCR. The obtained PCR mixture was purified with QIAquick PCR 
Purification Kit (Qiagen, 28104) and mutated plasmids were amplified in E. coli. Mutagenesis 
was verified by sequencing the purified plasmid. 
 
Genome editing 
The N-terminal HA-tagged hATG8 cell lines were generated with homology PCR templates 
containing 87 bp of GABARAP/GABARAPL1/GABARAPL2/LC3B-5’UTR including the start 
codon followed by the Blasticidine resistance gene, P2A, HA and 92bp downstream of the 
start codon of the corresponding hATG8 gene. For the C-terminal ACSL3-NeonGreen cell line, 
we used a homology PCR template containing 75 bp of the last exon of ACSL3, the 
NeonGreen ORF (Allele Biotech), T2A and the Blasticidine resistance gene ending with 84 bp 
downstream of the last exon of ACSL3. sgRNAs for hATG8s and ACSL3, designed with the 
online design tool from the Broad Institute 
(https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design) were clone into 
BSbI digested px330 (Addgene #42230), a SpCas9 expressing plasmid (sgRNA: GABARAP: 
GGAGGATGAAGTTCGTGTAC, GABARAPL1: TGCGGTGCATCATGAAGTTC, 























ACSL3: AGAAAATAATTATTCTCTTC). HeLa cells were seeded in a 6-well plate and 
transfected with Lipofectamin 2000 according to the manufacturer’s instructions with sgRNA 
and corresponding homology PCR template. 48 hrs later cells were selected with 4 µg/ml 
Blasticidine and subjected to single cell selection in 96-well plates. Cells with mNeonGreen 
insertion were FACS sorted. Correct introduction of the tag was verified by PCR and 
sequencing. 
 
Antibodies and dyes 
For immunoblotting the following primary antibodies were used at a concentration of 1:1000 
in 5 % milk-TBS-T or 5 % BSA-TBS-T or 0.2 % I-Block-TBS-T: ACSL3 (Santa Cruz, sc-
166374), alpha-Tubulin (Abcam, ab64503), ATG7 (Cell Signaling, 8558), Calnexin (Cell 
Signaling, 2433), c-myc (Bethyl, A190-104A), COXIV (Cell Signaling, 4850), DDRGK1 (Sigma, 
HPA013373), GM130 (Abcam, ab52649), HA (Cell Signaling, 3724S/Biolegend, 901501), 
LaminA/C (Abcam, ab108595), mNeonGreen (Chromotek, 32F6), PCNA (Santa Cruz, sc-
7907), p62 (MBL, PM045/BD, 610832), UBA5 (Proteintech, 12093-1-AP/Sigma, HPA017235), 
UFC1 (Proteintech, 15783-1-AP), UFL1 (Abcam, ab226216), UFM1 (Abcam, ab109305) or at 
a concentration of 1:100 in 5 % milk-TBS-T: c-myc (Monoclonal Antibody Core Facility, 
Helmholtz Zentrum Munich, 9E1, rat IgG1), c-myc (Monoclonal Antibody Core Facility, 
Helmholtz Zentrum Munich, 9E10, mouse IgG). As secondary antibodies we used horseradish 
peroxidase coupled anti-mouse (Promega, W402B), anti-rabbit (Promega, W401B) and anti-
goat (Dianova, 705035003) antibodies at a concentration of 1:10 000 and anti-rat IgG1 
(Monoclonal Antibody Core Facility, Helmholtz Zentrum Munich) antibody at a concentration 
of 1:100 in 1 % milk-TBS-T or 1 % BSA-TBS-T or 0.2 % iBlock-TBS-T. The following primary 
antibodies and lipid stains were used for immunofluorescence in 0.1 % BSA-PBS: Calnexin 
(Stressgen, SPA-860, 1:100), HA (Roche, 11867423001, 1:50), LAMP1 (DSHB, H4A3, 1:50), 
LC3 (MBL, PM036, 1:500), p62 (BD, 610832, 1:500), SEC13 (Novus, AF9055-100, 1:300), 
HCS LipidTOX™ Red Phospholipidosis Detection Reagent (Thermo Scientific, H34351, 
1:1000) and HCS LipidTOX™ Deep Red Neutral Lipid Stain (Thermo Scientific, H34477, 
1:500). The following fluorophore conjugated secondary antibodies from Thermo Fisher were 
use at a concentration of 1:1000 in 0.1 % BSA-PBS: anti-mouse IgG Alexa Fluor 488 (A-


























For siRNA knockdowns, cells were reversely transfected with Lipofectamine RNAiMax 
(Thermo Fisher Scientific) according to the manufacturer’s guidance with 30 nM of the 
following siRNAs from Dharmacon/Horizon Discovery and harvested 72 hrs after transfection: 
sictrl UGGUUUACAUGUUUUCCUA, siACSL3#1 UAACUGAACUAGCUCGAAA, siACSL3#2: 
GCAGUAAUCAUGUACACAA, siGABARAP GGUCAGUUCUACUUCUUGA, siGABARAPL1 
GAAGAAAUAUCCGGACAGG, siGABARAPL2 GCUCAGUUCAUGUGGAUCA, siLC3B 
GUAGAAGAUGUCCGACUUA. Plasmids were transiently transfected with Lipofectamine 
2000 (Thermo Fisher Scientific) according to the instruction of the manufacturer or with 10 mM 
PEI (Polyethylenimine) and cells were collected after 48 hrs.  
 
Immunoblotting 
Cell were lysed in RIPA (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.5 % sodium desoxycholate, 
1 % NP-40, 0.1 % SDS, 1x EDTA-free protease inhibitor (Roche), 1x phosphatase inhibitor 
(Roche)) for 30 min. After elimination of cell debris by centrifugation, proteins were diluted with 
3x loading buffer (200 mM Tris-HCl [pH 6.8], 6 % SDS, 20 % Glycerol, 0.1 g/ml DTT, 0.1 mg 
Bromophenol blue) and boiled at 95°C. Proteins were size separated by SDS-PAGE with self-
casted 8 %, 10 %, 12 % and 15 % gels followed by protein transfer onto nitrocellulose 
membranes (GE Healthcare Life Sciences, 0.45 µm). For better visibility of endogenous HA-
hATG8s membranes were boiled for 5 min in PBS after protein transfer. For GST pulldowns, 
equal sample loading was confirmed with 5 min Ponceau staining (0.2 % Ponceau S, 3 % 
acetic acid) followed by a 10 min TBS-T washing step. Blots were blocked in TBS-T (20 mM 
Tris, 150 mM NaCl, 0.1 % Tween-20) supplemented with 5 % low fat milk (Roth) or 5 % BSA 
(Albumin from bovin serum, Sigma) or 0.2 % I-Block protein based blocking reagent (Thermo 
Fisher) for 1 hr. Primary antibodies were incubated overnight followed by several wash steps 
with TBS-T and incubation with secondary antibodies for 1 hr at room temperature. After 




All steps were carried out at room temperature. Cells growing on glass coverslips in 12-well 























with 0,1 % Trition-X-100 in PBS or 0,1 % Saponin in PBS for 15 min and 1 hr blocking in 1 % 
BSA-PBS. First and secondary antibody incubation was done sequentially for 1 hr at room 
temperature in 0.1 % BSA-PBS followed by mounting of the coverslips with ProlongGold 
Antifade with Dapi (Thermo Fisher). In between each step, cells were washed several times 
with PBS. Cells were imaged with a LSM 800 Carl Zeiss microscope using 63x oil-immersion 
objective and ZEN blue edition software and analyses with ImageJ (version 1.52).  
 
Sample preparation for SRRF imaging 
For super-resolution radial fluctuations (SRRF; ref. PMID: 29852248) imaging, 
GABARAPL2endoHA/ACSL3endoNeonGreen cells were seeded on 18 mm diameter coverslips at a 
density of 2x105 per 35 mm dish. Following overnight incubation, cells were fixed with 4 % 
PFA for 15 min at room temperature, washed three times with 1x PBS followed by a 5 min 
additional washing with 50 mM NH4Cl. Permeabilization was performed for 5 min with 0.5 % 
Triton X-100 and blocking for 40 min in 1 % BSA. Following antibodies were used at room 
temperature in 1 % BSA for 1 hr. Rabbit polyclonal anti-Calnexin (Abcam, ab22595, 1:500), 
mouse monoclonal anti-HA (Sigma, H9658, 1:500) and rabbit polyclonal anti-UBA5 (PTGLab, 
12093-a-AP, 1:250).  
 
Acquisition of SRRF images 
Confocal microscopy imaging of immunostained HeLa cells was performed on Andor 
Dragonfly spinning disk using a Nikon Ti2 inverted optical microscope (60x TIRF objective 
(Plan-APOCHROMAT 60 × /1.49 Oil)). Fluorescence was collected with an EMCCD camera 
(iXon Ultra 888, Andor). Images were acquired using SRRF-Stream mode in Fusion (version 
2.1, Andor) with additional 1.5x magnification. Following imaging parameters were used. 
SRRF Frame count: 150, SRRF Radiality Magnification: 4x, SRRF Ring Radius: 1.4 px, SRRF 
Temporal Analsysis: Mean and SRRF FPN correction: 75 frames. 
 
Immunoprecipitation  
Frozen cell pellets from 4x15 cm cell culture plates for mass spectrometry or 2x10 cm cell 
culture plate for immunoblotting were lysed in Glycerol buffer (20 mM Tris [pH 7.4], 150 mM 
NaCl, 5 mM EDTA, 0.5 % Triton-X-100, 10 % Glycerol, 1x protease inhibitor, 1x phosphatase 
inhibitor) for 30 min at 4° C with end-over-end rotation. Lysates were cleared from cell debris 























overnight immunoprecipitation at 4° C with pre-equilibrated anti-HA-agarose (Sigma) or anti-
c-myc-agarose (Thermo fisher). Agarose beads were washed five times with Glycerol buffer 
followed by elution of proteins with 3x loading buffer and boiling of the samples at 95° C. 
Samples were then analyzed by SDS-PAGE (self-casted or BioRad’s 4-20 % gels) followed 
by immunoblotting or in-gel tryptic digestion. 
 
Mass spectrometry 
SDS-PAGE gel lines were cut in 12 equal size bands, further chopped in smaller pieces and 
placed in 96 well plates (one band per well). Gel pieces were washed with 50 mM ammonium 
bicarbonate (ABC)/50 % EtOH buffer followed by dehydration with EtOH, reduction of proteins 
with 10 mM DTT in 50 mM ABC at 56° C for 1 hr and alkylation of proteins with 55 mM 
iodacetamide in 50 mM ABC at room temperature for 45 min. Prior to overnight trypsin-digest 
(12 ng/ul trypsin in 50 mM ABC, Promega) at 37° C, gel pieces were washed and dehydrated 
as before. Peptide were extracted from gel pieces with 30 % acetonitrile/3 % trifluoroacetic 
acid (TFA), 70 % acetonitrile and finally 100 % acetonitrile followed by desalting on custom-
made C18-stage tips. Using an Easy-nLC1200 liquid chromatography (Thermo Scientific), 
peptides were loaded onto 75 µm x 15 cm fused silica capillaries (New Objective) packed with 
C18AQ resin (Reprosil- Pur 120, 1.9 µm, Dr. Maisch HPLC). Peptide mixtures were separated 
using a gradient of 5 %–33 % acetonitrile in 0.1 % acetic acid over 75 min and detected on an 
Q Exactive HF mass spectrometer (Thermo Scientific). Dynamic exclusion was enabled for 30 
s and singly charged species or species for which a charge could not be assigned were 
rejected. MS data were processed with MaxQuant (version 1.6.0.1) and analyzed with Perseus 
(version 1.5.8.4, http://www.coxdocs.org/doku.php?id=perseus:start). IP experiments from 
GABARAPL2endoHA and control parental HeLa cells were performed in duplicates and 
triplicates, respectively. Matches to common contaminants, reverse identifications and 
identifications based only on site-specific modifications were removed prior to further analysis. 
Log2 heavy/light ratios were calculated. A threshold based on a log2 fold change of greater 
than 1.5-fold or less than -1.5-fold was chosen so as to focus the data analysis on a smaller 
set of proteins with the largest alterations in abundance. Additional requirements were at least 
two MS counts, unique peptides and razor peptides as well as absence in IPs from parental 
HeLa control cells. For functional annotations, the platform DAVID (https://david.ncifcrf.gov/) 


























For isolation of the endoplasmic reticulum the Endoplasmic Reticulum Isolation Kit (Sigma, 
ER0100) was used and all steps were carried out according to the manufacturer’s guidance. 
Each sample consisted of cells derived from 4x10 cm cell culture plates.  
 
Protein expression and purification 
For protein expression and purification, pET-60-DEST plasmids containing wild-type or mutant 
versions of GABARAPL2 were transformed in Rosetta E. coli. Bacteria were grown in LB 
medium at 37° C at 200 rpm and induced with 1 mM IPTG when an OD600nm of 0.5-0.6 was 
reached. After 4 hrs, bacteria were harvested by centrifugation and resuspended in lysis buffer 
(150 mM NaCl, 50 mM Tris [pH 8.0], 100 µg/ml Lysozyme, 1 mM PMSF, 1mM DTT) and 
sonified at an amplitude of 50 % for 10 min (30 sec sonification/30 sec break). Lysates were 
cleared from cell debris by centrifugation and incubated overnight with pre-equilibrated 
glutathione Sepharose 4B (GE Healthcare) at 4° C with end over end rotation. Glutathione 
beads were washed with 150 mM NaCl, 50 mM Tris [pH 8.0] and GST-proteins were eluted 
with 10 mM reduced glutathione in 50 mM Tris [pH 8.0]. GST-proteins were dialyzed overnight 
in TBS with Slide-A-Lyzer cassettes (Thermo Fisher). Purified GST-proteins were stored at -
80° C until further usage. 
 
Pulldown assay 
Glutathione Sepharose 4B beads were always freshly coupled prior to pulldown assay. For 
one reaction, 40 µl pre-equilibrated glutathione beads slurry was couple to an appropriate 
amount of GST-protein overnight at 4° C with end over end rotation. On the next day protein-
coupled glutathione beads were washed with 150 mM NaCl, 50 mM Tris [pH 8.0]. Cells from 
2x10 cm cell culture plates per sample were lysed in 600 µl Glycerol buffer for 1 hr. After 
clearance of cell debrides by centrifugation lysates were precleared for 1 hr at 4° C with pre-
equilibrated uncoupled glutathione beads prior to the adjustment of protein concentrations. To 
ensure equal addition of the different GST-proteins, protein-beads binding was monitored by 
serial dilutions on Coomassie (0.1 % Brilliant Blue R, 40 % EtOH, 10 % Acetic acid) stained 
acrylamide gels. Accordingly coupled beads were diluted and 40 µl per sample was added. 
After overnight incubation at 4° C, beads were washed with Glycerol buffer and boiled for 5 

























HeLa cells were seeded on glass coverslips in 12-well plates. The next day, cells were 
transfected with TETOn-mCherry-GFP-RAMP4 at 500 ng per well with FuGENE® HD 
transfection reagent (Promega), using manufacturer’s recommendations and in the presence 
of 4 μg/ml doxycycline. After 24 hrs, cells were placed into fresh complete DMEM medium and 
doxycycline was removed. 40 hrs after initial transfection, cells were starved with EBSS 
medium for 8 hrs in the presence of either EtOH or oleic acid. Cells were then fixed with 4 % 
paraformaldehyde in PBS, pH 7.2 at room temperature for 10 min, washed 3x 5 min with PBS, 
stained with 1/5000 DAPI in the penultimate wash and mounted in Dako fluorescent mounting 
medium (Dako) onto glass slides. Images were captured with a Nikon A1R TiE confocal 
microscope using a 100x 1.4 NÅ objective (Nikon Instruments). All confocal images are shown 
as z-projections of at least 3 z-steps. All quantifications were performed on a minimum of 90 
cells across three biological replicates and the standard error of the mean was determined for 
each data set. Cells were single blind scored for red-only puncta (autolysosomes). 
 
Data availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository 
with the dataset identifier PXD016734. 
 
Statistical analysis 
Quantification and statistical analysis were done with imageJ and Phyton (version 3.7). 
Statistical significance was calculated with Student’s t test and data represent ± SEM 
(standard error of the mean). Statistical analysis of MS data was done with Perseus. 
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Fig. 1. Establishment of cells carrying endogenously HA-tagged LC3s and GABARAPs. 
(A) GABARAPL2endoHA and parental HeLa cell lysates were analyzed by immunoblotting using 
anti-HA and -PCNA antibodies. The latter was used as loading control. (B,C) 
GABARAPL2endoHA cells were reversely transfected for 72 hrs with non-targeting (sictrl) or 
GABARAPL2 siRNA followed by lysis and immunoblot analysis (B) or fixation and 
immunolabeling (C) using an anti-HA antibody. Scale bar: 10 µm. (D) GABARAPL2endoHA cells 
were treated as indicated and subjected to lysis and immunoblotting. (E-G) GABARAPL2endoHA 
cells treated with indicated inhibitors were immunolabeled with anti-p62 (E), anti-LAMP1 (F) 


























Fig. 2. Endogenous GABARAPL2 interactome. (A) Scatterplot represents interaction 
proteomics of SILAC labeled GABARAPL2endoHA cells differentially treated with Torin1 and 
BafA1 (light) or ATG7 inhibitor (heavy). Significantly enriched proteins upon Torin1 and BafA1 
combination treatment or ATG7 inhibition are highlighted in red and blue, respectively. 
Proteins in grey are unchanged. (B,C) Immunoblot analysis of anti-HA immunoprecipitates 
from lysates derived from parental HeLa and GABARAPL2endoHA cells which were either 



























Fig. 3. Stabilization of GABARAPL2 through ACSL3. (A) GABARAPL2endoHA cells were 
treated as indicated and subjected to lysis and analyzed with immunoblotting and anti-ACSL3 























GABARAPL2 siRNA were lysed followed by immunoblotting and analysis with indicated 
antibodies. (C-F) GABARAPL2endoHA (C), GABARAPendoHA (D), GABARAPL1endoHA (E) and 
LC3BendoHA (F) cells were reversely transfected with two different ACSL3 siRNAs. Lysates 
were analyzed by immunoblotting with indicated antibodies. Data represent mean ±SEM. 
Statistical analysis (n = 4) of the HA/PCNA ratio normalized to sictrl was performed using 
Student’s t-test (*p<0.05, **p<0.01). (G) GABARAPL2endoHA cells reversely transfected with 
siRNAs targeting ACSL3 for 72 hrs were treated with BafA1 or Btz and analyzed by 
immunoblotting. Data represents mean ±SEM. Statistical analysis (n = 3) of the HA/PCNA 



























Fig. 4. Colocalization of GABARAPL2 and ACSL3 at the ER. (A) GABARAPL2endoHA and 
GABARAPL2endoHA/ACSL3endoNeonGreen cells as well as parental HeLa cells transiently 
transfected with TOMM20-NeonGreen were lysed and analyzed by immunoblotting with 























GABARAPL2endoHA/ACSL3endoNeonGreen cells immunolabeled with anti-Calnexin. Magnified view 
of colocalization events of ACSL3endoNeonGreen and the ER marker Calnexin are shown in insets. 
Scale bars: 5 µm. (C) GABARAPL2endoHA/ACSL3endoNeonGreen cells were treated with oleic acid 
or EtOH (control) for 24 hrs followed by fixation and labeling of phospholipids and neutral lipids 
with HCS LipidTox lipid stains. Scale bar: 10 µm. Two confocal planes are shown for oleic acid 
treatment. (D), Representative SRRF image of GABARAPL2endoHA/ACSL3endoNeonGreen cells 
after immunolabeling with anti-HA. Insets show magnified view of colocalization events. Scale 



























Fig. 5. LDS of GABARAPL2 mediate ACSL3 binding and ER recruitment.  (A) Scheme of 
wild-type (WT) ACSL3 and fragments with known domains and potential LIRs. (B) Pulldown 
assays using GST-tagged WT or ΔLBS GABARAPL2 protein incubated with lysates from 
HeLa cells expressing WT or fragmented ACSL3 were analyzed by immunoblotting and 
Ponceau staining. (D) Subcellular fractionation of HeLa cells stably expressing WT or ΔLBS 
GABARAPL2 followed by immunoblot analysis with indicated antibodies. PNS, post nuclear 



























Fig. 6. UBA5 binds to and colocalizes with ACSL3 and GABARAPL2. (A, B) Immunoblot 
analysis of anti-HA immunoprecipitates from lysates derived from parental HeLa and 
GABARAPL2endoHA cells either transiently transfected for 48 hrs with myc-UBA5 (A) or left 
untreated (B) and analyzed with indicated antibodies. (C) Representative SRRF image of 
GABARAPL2endoHA/ACSL3endoNeonGreen cells immunolabeled with anti-UBA5. Colocalization 
events of ACSL3endoNeonGreen and UBA5 are shown enlarged in insets. Scale bars: 5 µm. (D) 























HA and -UBA5. Colocalization events of ACSL3endoNeonGreen, GABARAPL2endoHA and UBA5 are 
shown in magnified insets. Scale bars: 5 µm. (E) Stable expressing ACSL3-HA cells were 
reverse transfected with sictrl or siGABARAPL2 for 72 hrs and transiently transfected with 
myc-UBA5 for 48 hrs followed by lysis, anti-HA immunoprecipitation and immunoblot analysis. 
(F) Parental HeLa and GABARAPL2endoHA cells transfected with myc-UBA5 were treated with 



























Fig. 7. ACSL3 and LD biogenesis regulate the ufmylation pathway. (A) GABARAPL2endoHA 
cells were transfected with ACSL3 siRNAs and treated with Btz or BafA1 followed by lysis and 























represents mean ±SEM. Statistical analysis (n = 3) of the indicated protein/PCNA ratio 
normalized to sictrl-DMSO was performed using Student’s t-test (*p<0.05, **p<0.01, 
***p<0.001). (C) GABARAPL2endoHA cells were treated with oleic acid or EtOH for 0.5, 4 or 8 
hrs prior to lysis and immunoblotting with indicated antibodies. (D) Quantitative analysis of C. 
Data represents mean ±SEM. Statistical analysis (n = 3) of the indicated protein/PCNA ratio 


























Fig. 8. Oleic acid inhibits ER-phagy. (A) HeLa cells were transiently transfected with 
mCherry-eGFP-RAMP4 and starved with EBSS for 8 hrs in combination with either EtOH or 
oleic acid. Red-only puncta were defined as reticulolysosomes. Scale bar: 10 μm. Inset scale 
bar: 2 μm. Arrowheads indicate reticulolysosomes. (B) Quantitative analysis of A. Data 
represents mean ±SEM. Statistical analysis (n = 3) was performed using Student’s t-test 
(*p<0.05). (C) Working model of ACSL3’s role in the ufmylation pathway. UBA5 is recruited to 
ACSL3 by GABARAPL2. Upon loss of ACSL3 or induction of LD biogenesis ufmylation 
components are downregulated and dynamics of UFM1 conjugation are altered. Dotted blue 
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Fig. S1. Endogenous epitope tagging of hATG8 and ACSL3 genes. (A) Experimental 
CRISPR/Cas9 workflow. (B,C) Sequence data from PCR products of the tagged 
GABARAPendoHA, GABARAPL1endoHA, GABARAPL2endoHA, LC3BendoHA cell lines (B) and the 
GABARAPL2endoHA/ACSL3endoNeonGreen cell line (C). Introduced CRISPR sequences are 
indicated in bold. 



















































































































































































































































































Fig. S2. Validation of endogenously HA-tagged hATG8 proteins. (A-C) GABARAPendoHA 
(A) GABARAPL1endoHA (B) LC3BendoHA (C) and parental HeLa (A-C) cells were lysed followed 
by immunoblotting and analysis with indicated antibodies. (D-F) GABARAPendoHA (D), 
GABARAPL1endoHA (E), LC3BendoHA (F) cell lines were reversely transfected with indicated 
siRNAs prior to immunoblot analysis. (G-I) GABARAPendoHA (G), GABARAPL1endoHA (H), 
LC3BendoHA (I) were treated as indicated followed by lysis and immunoblotting. (J) Annotation 
enrichment analysis of candidate GABARAPL2-interacting proteins with log2 SILAC H/L ratios 
≥1.5 or ≤-1.5. The bar graphs show significantly overrepresented UniProt keywords.  



















































Fig. S3. ACSL3 is not an autophagy substrate. (A,B) GABARAPL2endoHA/ACSL3endoNeonGreen 
cells were transfected with indicated siRNAs prior to immunolabeling with Calnexin (A) or 
SEC13 (B). Scale bar: 10 µm. 
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Fig. S4. Effects of ACSL3 depletion and LD induction on ufmylation. (A) Amino acid 
sequences of potential LIRs and UIM in ACSL3. (B) Immunoblot analysis of HeLa cells stably 
expressing wild-type (WT) and LIR-binding deficient (ΔLBS) GABARAPL2. (C) Quantitative 
analysis from Fig. 7A. Data represents mean ±SEM. Statistical analysis (n = 3) of the indicated 
protein/PCNA ratio normalized to sictrl-DMSO was performed using Student’s t-test (*p<0.05, 
**p<0.01, ***p<0.001). (D) Quantitative analysis of Fig. 7C. Data represents mean ±SEM. 
Statistical analysis (n = 3) of the indicated protein/PCNA ratio normalized to 0.5 hrs EtOH was 
performed using Student’s t-test (*p<0.05, **p<0.01). 
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